Home
>
US Stocks
>
Sage Therapeutics Inc
Sage Therapeutics Inc
SAGE

Sage Therapeutics Inc (SAGE)

$41.223.96%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
41.33
Today Low/High
40.74 / 41.6
52 Week Low/High
$40.82 / $98.39
P/E ratio
3.77
Market Cap
$2.51B

Company Details

Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. The Company is pursuing new pathways with the goal of improving brain health, and its depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Its mission is to make medicines that matter so people can get better, sooner.
Organisation
Sage Therapeutics Inc
Headquaters
Cambridge, Massachusetts, US
Employees
298
Industry
Health Technology
CEO
Jeffrey Jonas

Discover more

Frequently Asked Questions

What is Sage Therapeutics Inc (SAGE) share price today?

Can Indians buy Sage Therapeutics Inc (SAGE) shares?

How can I buy Sage Therapeutics Inc (SAGE) shares from India?

Can Fractional shares of Sage Therapeutics Inc (SAGE) be purchased?

What are the documents required to start investing in Sage Therapeutics Inc (SAGE) stocks?

We are a SEBI registered investement advisor